loadpatents
Patent applications and USPTO patent grants for TenNor Therapeutics Limited.The latest application filed is for "application of rifamycin-quinolizidone conjugate molecule and pharmaceutically acceptable salt thereof".
Patent | Date |
---|---|
Application Of Rifamycin-quinolizidone Conjugate Molecule And Pharmaceutically Acceptable Salt Thereof App 20220087990 - MA; Zhenkun ;   et al. | 2022-03-24 |
Solid Dispersion Of Rifamycin-nitroimidazole Coupling Molecule And Application Thereof App 20210338645 - LIU; Yu ;   et al. | 2021-11-04 |
Penam derivatives for treating bacterial infections Grant 11,040,987 - Ai , et al. June 22, 2 | 2021-06-22 |
Penam Derivatives For Treating Bacterial Infections App 20210070774 - Ai; Huibing ;   et al. | 2021-03-11 |
New Use Of Rifamycin-nitroimidazole Conjugate Molecule App 20200093807 - MA; Zhenkun ;   et al. | 2020-03-26 |
New Use Of Rifamycin-quinolizidone Dual-action Molecule App 20200061047 - MA; Zhenkun ;   et al. | 2020-02-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.